Tech & Innovation in Healthcare

Industry Notes:

Using Breathalyzers to Diagnose COVID-19

On April 14, 2022, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for a diagnostic test that can detect compounds associated with COVID-19 in breath samples. The InspectIR COVID-19 Breathalyzer showed to have 91.2 percent sensitivity (percentage of correctly identified positive samples) and 99.3 percent specificity (percentage of correctly identified negative samples) in a study [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Tech & Innovation in Healthcare

View All